164 related articles for article (PubMed ID: 9927744)
1. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
[TBL] [Abstract][Full Text] [Related]
2. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
Leung WH; Meng ZQ; Hui G; Ho WK
Biochim Biophys Acta; 2004 Nov; 1675(1-3):62-70. PubMed ID: 15535968
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
5. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
Angov E; Aufiero BM; Turgeon AM; Van Handenhove M; Ockenhouse CF; Kester KE; Walsh DS; McBride JS; Dubois MC; Cohen J; Haynes JD; Eckels KH; Heppner DG; Ballou WR; Diggs CL; Lyon JA
Mol Biochem Parasitol; 2003 May; 128(2):195-204. PubMed ID: 12742586
[TBL] [Abstract][Full Text] [Related]
6. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
8. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
Gupta PK; Mukherjee P; Dhawan S; Pandey AK; Mazumdar S; Gaur D; Jain SK; Chauhan VS
Clin Vaccine Immunol; 2014 Jun; 21(6):886-97. PubMed ID: 24789797
[TBL] [Abstract][Full Text] [Related]
9. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody.
Nurul AA; Rapeah S; Norazmi MN
Trop Biomed; 2010 Apr; 27(1):60-7. PubMed ID: 20562815
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
Nurul AA; Norazmi MN
Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
Mazumdar S; Mukherjee P; Yazdani SS; Jain SK; Mohmmed A; Chauhan VS
Infect Immun; 2010 Feb; 78(2):872-83. PubMed ID: 19933832
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.
Zhou Z; Schnake P; Xiao L; Lal AA
Protein Expr Purif; 2004 Mar; 34(1):87-94. PubMed ID: 14766303
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
[TBL] [Abstract][Full Text] [Related]
15. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
John CC; O'Donnell RA; Sumba PO; Moormann AM; de Koning-Ward TF; King CL; Kazura JW; Crabb BS
J Immunol; 2004 Jul; 173(1):666-72. PubMed ID: 15210830
[TBL] [Abstract][Full Text] [Related]
16. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.
Pang AL; Hashimoto CN; Tam LQ; Meng ZQ; Hui GS; Ho WK
Infect Immun; 2002 Jun; 70(6):2772-9. PubMed ID: 12010962
[TBL] [Abstract][Full Text] [Related]
17. Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate.
Epp C; Kauth CW; Bujard H; Lutz R
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):61-72. PubMed ID: 12651002
[TBL] [Abstract][Full Text] [Related]
18. Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.
Lyon JA; Carter JM; Thomas AW; Chulay JD
Mol Biochem Parasitol; 1997 Dec; 90(1):223-34. PubMed ID: 9497045
[TBL] [Abstract][Full Text] [Related]
19. A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.
Cowan GJ; Creasey AM; Dhanasarnsombut K; Thomas AW; Remarque EJ; Cavanagh DR
PLoS One; 2011; 6(10):e26616. PubMed ID: 22073118
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.
O'Donnell RA; de Koning-Ward TF; Burt RA; Bockarie M; Reeder JC; Cowman AF; Crabb BS
J Exp Med; 2001 Jun; 193(12):1403-12. PubMed ID: 11413195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
